Gandini A, De Maayer T, Munien C, Bertrand K, Cairns R, Mayne A, et al. Intestinal fatty acid binding protein (I-FABP) and CXC3L1 evaluation as biomarkers for patients at high-risk for coeliac disease in Johannesburg, South Africa. Cytokine. 2022;157:155945. https://linkinghub.elsevier.com/retrieve/pii/S1043-4666(22)00154-5
Intestinal fatty acid binding protein (I-FABP) and CXC3L1 evaluation as biomarkers for patients at high-risk for coeliac disease in Johannesburg, South Africa.
By Peter Matlawa|2023-03-02T15:58:13+02:00February 21, 2023|2022: July to September|Comments Off on Intestinal fatty acid binding protein (I-FABP) and CXC3L1 evaluation as biomarkers for patients at high-risk for coeliac disease in Johannesburg, South Africa.
Share This Story, Choose Your Platform!
About the Author: Peter Matlawa
Related Posts
Performance of glucagon stimulation test in diagnosing central adrenal insufficiency in children when utilising the Roche Elecsys(®) cortisol II assay: a pilot study.